Company: RNGE
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023395
Chunk: 30

Company: RANGE IMPACT, INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 30
---
 Net proceeds from disposition of Graphium Biosciences 
     -  
     100 
  
    Net cash provided by (used in) investing activities 
     (328,866) 
     430,100 

    Cash flows from financing activities: 

    Issuance of shares for cash 
     1,150,000  
     1,000,000 
  
    Repayment of line of credit 
     (200,000) 
     (300,000)
  
    Repayment of long-term debt 
     (522,143) 
     (1,202,944)
  
    Net cash provided by (used in) financing activities 
     427,857  
     (502,944)

    Net increase (decrease) in cash and cash equivalents 
     118,102  
     (1,932,214)

    Cash and cash equivalents - beginning of period 
     167,286  
     2,176,800 
  
    Cash and cash equivalents - end of period 
    $285,388  
    $244,586 

    Supplemental disclosure of cash flow information: 

    Cash paid during the period for: 

    Interest 
    $148,810  
    $43,303 

    Supplemental schedule of Non-Cash Investing and Financing Activities: 

    Conversion of line of credit and short term note to bank term loan 
    $1,800,000  
     - 
  
    Debt reduction from equipment returned to lender 
    $914,803  
     - 
  
    Debt forgiveness related to Collins Building asset disposal 
    $-  
    $2,940,836 

See
accompanying notes to the consolidated financial statements.

7

RANGE
IMPACT, INC.

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

THREE
AND NINE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024

(Unaudited)

1.
BUSINESS OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Range
Impact, Inc. (the “Company”, “we”, “us” or “our”), was incorporated in the State of Nevada
on June 29, 2007.

Since inception, the Company has undergone several
strategic transformations conducting prior operations under the names Legend Mining Inc., Stevia First Corp.,